Oncology & Hematology Fellowship | NYU Grossman Long Island School of Medicine | NYU Langone Health

Skip to Main Content
Division of Oncology & Hematology Oncology & Hematology Fellowship

Oncology & Hematology Fellowship

NYU Grossman Long Island School of Medicine’s Oncology and Hematology Fellowship seeks to develop a diverse cadre of physicians who are adept at the prevention, screening, diagnosis, and treatment of a broad range of cancers and blood cancers, as well as noncancerous blood disorders.

Fellows are trained in all procedures relating to oncology and hematology, including bone marrow aspiration, biopsy and interpretation, coagulation testing, blood banking, chemotherapy administration, and stem cell transplantation. Our program offers the full range of clinical experiences, including autologous stem cell transplantation, clinical trials, a dedicated inpatient oncology unit, and an outpatient chemotherapy and transfusion treatment suite.

As a member of the SWOG Cancer Research Network, comprised of researchers who design and conduct publicly funded clinical trials, we serve as a site for numerous investigational drug and treatment trials for hematologic as well as malignant disease.

Graduates of our fellowship are prepared with the background and education necessary to pass the American Board of Internal Medicine board certification examinations in medical oncology and hematology; in the past five years, our program has had a 100 percent pass rate for oncology boards.

Program Details

Our three-year Oncology and Hematology Fellowship accepts three fellows per year and involves comprehensive clinical training in both medical oncology and hematology, along with time to pursue an original research project.

Oncology and Hematology Fellowship program aims include the following:

  • provide diverse patient experiences under adequate faculty supervision that allows for the acquisition of the medical knowledge needed for independent practice in the field of hematology–oncology
  • facilitate both clinical and didactic encounters, during which the interdisciplinary and interprofessional exchange of information is encouraged
  • teach enhanced communication skills and the ability to function within the healthcare system in a professional manner
  • provide research opportunities, as well as evidence-based discussions that foster life-long learning and continued excellence in patient care in the midst of a rapidly evolving field of medicine

All fellows are assigned to a faculty mentor, with whom they work to develop an individualized plan to reach their research and clinical subspecialty goals. Our fellows frequently present their work at national meetings, including the American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH), and San Antonio Breast Cancer Symposium (SABCS), and publish in peer-reviewed journals.

Participants obtain valuable clinical experience caring for diverse patient populations at NYU Langone Hospital—Long Island and Perlmutter Cancer Center at NYU Langone Long Island Hematology and Oncology. Fellowship training locations feature a 32-chair state-of-the-art infusion center and a dedicated inpatient unit for ambulatory and inpatient treatments.

Fellows also have access to a wide variety of pathology, including more than 2,000 cancer cases diagnosed annually, and treatments including intensity modulated radiation therapy, monoclonal antibody-based therapy, hematopoietic stem cell transplantation, and clinical trials.

The fellowship is overseen by Marc J. Braunstein, MD, PhD, program director, and is administered by the Division of Oncology and Hematology, part of the Department of Medicine.


Fellows participate in providing the full array of ambulatory and inpatient services and coordinate complex treatment protocols that involve collaboration with surgical oncology, infectious disease, rehabilitation, CyberKnife radiosurgery, and genetics counseling. Care is provided with the supervision of eleven full-time subspeciality-based attending physicians who are double board certified in hematology and medical oncology.

The didactic portion of the curriculum aims to adapt to modern learners. The educational program includes weekly hematology and oncology teaching conferences, grand rounds, specialty tumor board meetings; a core summer orientation lecture series, simulation, journal clubs, and board review; clinical trials curriculum; and a book club with invited speakers. Available elective experiences include oncology subspecialties, malignant hematology, blood bank, radiation oncology, stem cell transplant, gynecologic oncology, neuro-oncology, palliative medicine, and research.

All fellows attend subspecialized clinics with faculty throughout the three-year training program and dedicate time to scholarly and research activities. Faculty research interests are broad. Some notable interests include immunotherapy for lung cancer, monoclonal antibodies for multiple myeloma, and tumor marker validation in breast and lung cancers.

First-Year Experience

During the first two years, our program emphasizes clinical training in oncology and hematology. Fellows alternate between inpatient consult and oncology service months, as well as subspeciality outpatient electives. Fellows spend 7 months rotating on the inpatient service, and attend a weekly subspeciality clinic for 6-month periods. First-year fellows also present their research proposals to a faculty committee by the end of the year.

Second-Year Experience

During the second year, fellows go on to outpatient rotations in monthly subspecialty clinics entirely in the ambulatory setting. Fellows also continue to work on their research projects.

Third-Year Experience

During the third year, fellows continue their outpatient experience and participate in sustained scholarly activity. Third-year fellows continue in a leadership role, overseeing junior fellows during continued outpatient experiences and have the opportunity to explore special interests via electives in pediatric oncology, gynecologic oncology, tumor pathology, cytogenetics, and molecular methods. Fellows spend one month at the stem cell transplant unit on NYU Langone’s Manhattan campus, an experience that involves autologous and allogeneic stem cell transplant and CAR T-cell therapies.

Fellows have two months of research time, three months for electives, and complete one-month rotations in bone marrow transplant, breast oncology, gastrointestinal oncology, genitourinary oncology, gynecologic oncology, lung oncology, and malignant hematology. Third-year fellows do not have on-call duties after the summer months.

How to Apply

To be eligible for the Oncology and Hematology Fellowship, you must complete three years of Accreditation Council for Graduate Medical Education–accredited training in internal medicine. Three positions are available for academic year 2024–25. Applications for the 2024–25 academic year are accepted beginning in June 2023. The official fellowship start date is July 1, 2024.

We only accept fellowship applications through the Electronic Residency Application Service (ERAS) run by the Association of American Medical Colleges. All interviews are held virtually throughout September and October. Applicants are notified via email no later than September 22, 2023, whether they are or are not selected for an interview. We accept individuals on J1 visas.

Contact Us

If you have questions about the Oncology and Hematology Fellowship, please contact Mia Persaud at mia.persaud@nyulangone.org or 516-663-1585.

Learn more about graduate medical education programs at NYU Grossman Long Island School of Medicine, and access information for house staff, including benefits, policies, and services.